No Results
"We are currently gathering more data to assess the safety of myovant.com. Your safety is our priority, and we're conducting a thorough analysis before providing a comprehensive evaluation."
Relugolix is a small molecule, gonadotropin-releasing hormone (GnRH) receptor antagonist, and an oral investigational drug candidate for the treatment of uterine fibroids, endometriosis, and advanced prostate cancer.
Traffic rank of myovant.com, compared to all other sites
↑ 317K+
Website ranking is crucial for evaluating myovant.com's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, myovant.com's global ranking has increased from 8,217,990 to 7,901,247.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to myovant.com based on traffic, content and site structure.
Learn more about ORGOVYX (relugolix), a prescription medicine used for the treatment of advanced prostate cancer. Please see Safety Information, full Prescribing Information, and Patient Information on this website.
Orgovyx alternatives
Roivant alternatives
Cortellis - Clarivate Analytics.
Cortellis alternatives
Unryudo alternatives
BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer.
Beigene alternatives
Pharmchoices alternatives
Capital-drug alternatives
Cell-innovator alternatives
Yakukensha alternatives
Redica Systems developed an essential tool for regulatory & compliance that provides data intelligence to quality & safety experts around the world. Learn more!
Redica alternatives
Check out some of our popular sites.